Neomycin Sulfate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 11 USDMF, 5 CEP/COS, 2 JDMF, 1 KDMF, 22 NDC API, 10 VMF, 10 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

159 FDF Dossiers, 114 FDA Orange Book, 4 Europe, 7 Canada, 4 South Africa, 30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM, OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION/DROPS;OTIC - EQ 3MG BASE/ML;10MG/ML;EQ 3.3MG BASE/ML;0.5MG/ML, OINTMENT;OPHTHALMIC - EQ 400 UNITS/GM;EQ 3.5MG BASE/GM;EQ 10,000 UNITS/GM

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 5 DKSH, 3 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 12 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 19 Actylis, 1 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 32 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 4 Finar, 10 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 35 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 17 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

52 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 42 Solubilizers, 39 Topical, 28 Parenteral, 25 Direct Compression, 24 Controlled & Modified Release, 21 Thickeners and Stabilizers, 21 Film Formers & Plasticizers, 19 Lubricants & Glidants, 18 Emulsifying Agents, 16 Granulation, 15 Co-Processed Excipients, 10 Surfactant & Foaming Agents, 9 Taste Masking, 6 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 2 Disintegrants & Superdisintegrants, 2 Rheology Modifiers, 1 Soft Gelatin

DIGITAL CONTENT

6 NEWS #PharmaBuzz

6 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 5 Finished Drug Prices

MARKET PLACE

56 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 2 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 50065 / DOSAGE - OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
DEXAMETHASONE(UNII: 7S5I7G3JQL) (DEXAMETHASONE - UNII:7S5I7G3JQL)	DEXAMETHASONE	1mg in 1
NEOMYCIN SULFATE(UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297)	NEOMYCIN	3.5mg in 1
POLYMYXIN B SULFATE(UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K)	POLYMYXIN B	10000[iU] in 1

Inactive Ingredients

Ingredient Name	Major Pharmaceuticals	Preferred Pharmaceuticals Inc.	Preferred Pharmaceuticals, Inc	Fera Pharmaceuticals	Preferred Pharmaceuticals, Inc.	Putney, Inc.
LANOLIN(7EV65EAW6H)
METHYLPARABEN(A2I8C7HI9T)
MINERAL OIL(T5L8T28FGP)
PETROLATUM(4T6H12BN9U)
PROPYLPARABEN(Z8IX2SC1OH)

Drug Product Composition: Neomycin Sulfate